ENTRADA THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 63.9% | 63.9% | -60.9% |
| FY2021 | -17.1% | -17.1% | -16.7% |
| FY2022 | -44.5% | -44.5% | -37.5% |
| FY2023 | -2.8% | -2.8% | -1.4% |
| FY2024 | 15.3% | 15.3% | 12.5% |
| FY2025 | -47.0% | -47.0% | -38.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2020 | 63.9% | 63.9% | -60.9% |
| FY2021 | -17.1% | -17.1% | -16.7% |
| FY2022 | -44.5% | -44.5% | -37.5% |
| FY2023 | -2.8% | -2.8% | -1.4% |
| FY2024 | 15.3% | 15.3% | 12.5% |
| FY2025 | -47.0% | -47.0% | -38.1% |